Skip to content
DraconiticResearch
Search Sources API
184,584 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Integrated Single-Cell and Transcriptomic Analysis Suggests a Cuproptosis-Related Phenotype and Potential Therapeutic Target in Acute Pancreatitis

  1. 1The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China
  2. 2Institute of Animal Nutrition and Feed Sciences, College of Animal Sciences, Zhejiang University, Hangzhou 310058, China

Abstract

Acute pancreatitis (AP) is an acute inflammatory disorder of the exocrine pancreas with limited therapies. Whether cuproptosis, a copper-dependent cell death pathway, contributes to AP pathogenesis remains unknown. We integrated single-cell transcriptomics (GSE279876), single-cell transcriptomics (GSE188819), and human whole-blood transcriptomic data (GSE194331) to evaluate 13 cuproptosis-related genes across cell types, along with pseudotime trajectory, regulatory networks, and cell–cell communication. Findings were validated in caerulein-induced severe acute pancreatitis (SAP) mouse models and acinar cell injury using histopathology, electron microscopy, flow cytometry, immunofluorescence, and biochemical assays. Single-cell analysis showed selective activation of a cuproptosis-related signature in acinar cells, with all 13 genes upregulated, most notably GIs and Fdx1. The cuproptosis-related gene signature score increased along with pseudotime, and exploratory transcription factor (TF) and cell–cell communication analyses suggested enrichment of SPI1 and AP-1 (FOS/JUN), alongside MIF/CCL inflammatory signals, which was corroborated in independent datasets. In vitro and in vivo, pancreatic tissues and pancreatic acinar cells in SAP exhibited copper accumulation, FDX1/DLAT upregulation, mitochondrial shrinkage, and cristae loss, which are consistent with a cuproptosis-related phenotype, and were all attenuated by Tetrathiomolybdate (TTM). These findings suggest that the inflammatory microenvironment may be associated with selective activation of a cuproptosis-related program in acinar cells in AP, and that copper chelation with TTM attenuates pancreatic injury, indicating a potential therapeutic strategy targeting copper dyshomeostasis.

Related

  1. 124 Integrated single-cell transcriptomic profiling of urine-derived cells as a strategy for non-invasive therapeutic monitoring in bladder cancer
    John Sfakianos, Amir Horowitz, Chong Li +16
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYSurgery & anaesthesiaDOAJ
  2. An AI-integrated pharmacophore and transcriptomic framework for rapid discovery of therapeutic leads for ischemic stroke
    Jinran Li, Zheng Zhou, Yongjun Zhao +11
    TargetomePeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  3. Cuproptosis in glioma: mechanisms, biological roles and therapeutic perspectives
    Hairui Cui, Sai Li, Zhijian Li +2
    Discover OncologyPeer-reviewedCC BYFull textOncologyDOAJ
  4. Ferroptosis and Cuproptosis in the Pathogenesis of Breast Cancer: Molecular Mechanisms, Crosstalk, and Therapeutic Perspectives
    Vitalii Ivchuk
    ZenodoPreprintCC BY 4.0Full textGeneral medicineZenodo
  5. Integrative transcriptomic analysis of peripheral blood identifies NETosis-associated programs and a stratified adaptive immune suppression pattern in severe acute pancreatitis
    Yaobin He, Kairui Liu, Rong Chen +2
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyPhysiologyPLOS
BibTeX
@article{xie2026integrated,
  title = {{Integrated Single-Cell and Transcriptomic Analysis Suggests a Cuproptosis-Related Phenotype and Potential Therapeutic Target in Acute Pancreatitis}},
  author = {Qingfeng Xie and Maoqin He and Qi Wang and Weiqin Li},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = oct,
  doi = {10.3390/ijms27209004},
  url = {https://www.mdpi.com/1422-0067/27/20/9004},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Integrated Single-Cell and Transcriptomic Analysis Suggests a Cuproptosis-Related Phenotype and Potential Therapeutic Target in Acute Pancreatitis
AU  - Qingfeng Xie
AU  - Maoqin He
AU  - Qi Wang
AU  - Weiqin Li
PY  - 2026
DA  - 2026/10/01
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27209004
UR  - https://www.mdpi.com/1422-0067/27/20/9004
AB  - Acute pancreatitis (AP) is an acute inflammatory disorder of the exocrine pancreas with limited therapies. Whether cuproptosis, a copper-dependent cell death pathway, contributes to AP pathogenesis remains unknown. We integrated single-cell transcriptomics (GSE279876), single-cell transcriptomics (GSE188819), and human whole-blood transcriptomic data (GSE194331) to evaluate 13 cuproptosis-related genes across cell types, along with pseudotime trajectory, regulatory networks, and cell–cell communication. Findings were validated in caerulein-induced severe acute pancreatitis (SAP) mouse models and acinar cell injury using histopathology, electron microscopy, flow cytometry, immunofluorescence, and biochemical assays. Single-cell analysis showed selective activation of a cuproptosis-related signature in acinar cells, with all 13 genes upregulated, most notably GIs and Fdx1. The cuproptosis-related gene signature score increased along with pseudotime, and exploratory transcription factor (TF) and cell–cell communication analyses suggested enrichment of SPI1 and AP-1 (FOS/JUN), alongside MIF/CCL inflammatory signals, which was corroborated in independent datasets. In vitro and in vivo, pancreatic tissues and pancreatic acinar cells in SAP exhibited copper accumulation, FDX1/DLAT upregulation, mitochondrial shrinkage, and cristae loss, which are consistent with a cuproptosis-related phenotype, and were all attenuated by Tetrathiomolybdate (TTM). These findings suggest that the inflammatory microenvironment may be associated with selective activation of a cuproptosis-related program in acinar cells in AP, and that copper chelation with TTM attenuates pancreatic injury, indicating a potential therapeutic strategy targeting copper dyshomeostasis.
SN  - 1422-0067
ER  -